Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India

Emerging Infectious Diseases
|September 29, 2021
PubMed

Insights

Mucormycosis, a fungal infection, surged during COVID-19, particularly in diabetic patients treated with steroids. Early diagnosis and surgical intervention are crucial for managing this severe rhino-orbital-cerebral disease.

Area of Science:

  • Infectious Diseases
  • Ophthalmology
  • Otolaryngology
  • Neurosurgery

Background:

  • The coronavirus disease (COVID-19) pandemic has been associated with a rise in mucormycosis cases.
  • Mucormycosis, a serious fungal infection, poses a significant threat, especially in immunocompromised individuals.

Purpose of the Study:

  • To investigate the epidemiology and clinical characteristics of mucormycosis in patients following COVID-19 treatment.
  • To identify risk factors and outcomes associated with rhino-sino-orbital and cerebral mucormycosis during the pandemic.

Main Methods:

  • Retrospective chart review of 178 patients with confirmed mucormycosis post-COVID-19 treatment.
  • Data collection included patient demographics, COVID-19 severity, comorbidities, treatment, clinical presentation, and outcomes.

Main Results:

  • The median time from COVID-19 detection to symptom onset was 28 days.
  • 73% of patients had moderate to severe COVID-19, and 74.2% had diabetes; 52.8% received steroids.
  • Nasal eschar was present in 75%, bone penetration in ~90%, and multifocal disease in 60%. Mortality was 15%, with 62% of deaths occurring in multifocal cases.

Conclusions:

  • Mucormycosis is a significant complication in COVID-19 patients, particularly those with diabetes and steroid use.
  • Aggressive surgical debridement is essential, and multifocal disease portends a poor prognosis.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
269
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
419
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
524
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
233
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
671
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
321